SLB vs UNH: Which Is the Better Buy?
Side-by-side comparison of Slb N.V. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Slb N.V. · Energy
$52.08
+8.6% upside to fair value
Med Conviction
Grade B
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+28.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
SLB |
UNH |
| Current Price |
$52.08 |
$375.21 |
| Fair Value Estimate |
$56.56 |
$481.06 |
| Upside to Fair Value |
+8.6%
|
+28.2%
|
| Market Cap |
$77.3B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
12.2x
|
15.0x
|
| Price / Sales |
2.1x
|
0.8x
|
| Price / FCF |
17.1x
|
14.4x
|
| Revenue Growth YoY |
+5.0%
|
+0.4%
|
| Gross Margin |
16.5%
|
22.5%
|
| Operating Margin |
13.4%
|
4.8%
|
| Return on Equity |
11.8%
|
14.6%
|
| Dividend Yield |
2.25% |
2.41% |
| FCF Yield |
5.83%
|
6.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
SLB N.V. is the world's largest oilfield services provider, operating four divisions (Digital & Integration, Reservoir Performance, Well Construction, and Production Systems) that span field development, drilling, subsea production, and carbon management for the global energy industry. The business carries a medium-quality profile: it benefits from deep technical expertise, a broad international …
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
SLB |
UNH |
| Zone Low |
$42.42 |
$360.80 |
| Zone High |
$48.08 |
$408.90 |
| In Buy Zone? |
No
|
Yes
|